Myocardial cell damage in human hypertension.

[1]  R. Virmani,et al.  Burden of myocardial damage in cardiac allograft rejection: Scintigraphic evidence of myocardial injury and histologic evidence of myocyte necrosis and apoptosis , 2000, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[2]  J. Díez,et al.  Apoptosis in hypertensive heart disease. , 1998, Current opinion in cardiology.

[3]  J. Marrugat,et al.  Evaluation of biopsy classification for rejection: relation to detection of myocardial damage by monoclonal antimyosin antibody imaging. , 1998, Journal of the American College of Cardiology.

[4]  K. Weber,et al.  Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation. , 1997, Circulation.

[5]  S. Kharbanda,et al.  Apoptosis and the heart. , 1997, Chest.

[6]  J. Díez,et al.  Cardiomyocyte apoptosis and cardiac angiotensin-converting enzyme in spontaneously hypertensive rats. , 1997, Hypertension.

[7]  E. Lakatta,et al.  Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat. , 1997, The American journal of physiology.

[8]  P. Anversa,et al.  Myocyte cell death and ventricular remodeling , 1997, Current opinion in nephrology and hypertension.

[9]  M. Bristow,et al.  Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure. , 1996, Circulation.

[10]  R. Virmani,et al.  Apoptosis in myocytes in end-stage heart failure. , 1996, The New England journal of medicine.

[11]  R. Vasan,et al.  The role of hypertension in the pathogenesis of heart failure. A clinical mechanistic overview. , 1996, Archives of internal medicine.

[12]  J. Cohn,et al.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.

[13]  A. Katz.  The cardiomyopathy of overload: an unnatural growth response. , 1995, European heart journal.

[14]  P Whelton,et al.  Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. , 1995, Hypertension.

[15]  C. Gohlke-Bärwolf,et al.  Prevention of bacterial endocarditis in Germany. , 1995, European heart journal.

[16]  I. Carrió,et al.  Evaluation of myocardial cell damage by In-111-monoclonal antimyosin antibodies in patients under chronic tricyclic antidepressant drug treatment. , 1995, Circulation.

[17]  A. Katz.  The Cardiomyopathy of Overload: An Unnatural Growth Response in the Hypertrophied Heart , 1994, Annals of Internal Medicine.

[18]  J. Laragh,et al.  Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension. , 1994, Journal of the American College of Cardiology.

[19]  J. Sadoshima,et al.  Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro , 1993, Cell.

[20]  I. Carrió,et al.  Detection of doxorubicin cardiotoxicity in patients with sarcomas by indium-111-antimyosin monoclonal antibody studies. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  R. Testa,et al.  Myocardial Blood Flow Distribution in Patients With Ischemic Heart Disease or Dilated Cardiomyopathy Undergoing Heart Transplantation , 1993, Circulation.

[22]  I. Carrió,et al.  Active myocardial damage without attending inflammatory response in dilated cardiomyopathy. , 1993, Journal of the American College of Cardiology.

[23]  I. Palacios,et al.  Brief report: recognition of acute myocarditis masquerading as acute myocardial infarction. , 1993, The New England journal of medicine.

[24]  Richard O. Hynes,et al.  Integrins: Versatility, modulation, and signaling in cell adhesion , 1992, Cell.

[25]  K. Baker,et al.  Angiotensin II and left ventricular growth in newborn pig heart. , 1991, Journal of molecular and cellular cardiology.

[26]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[27]  P. Anversa,et al.  Cardiac hypertrophy and ventricular remodeling. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[28]  I. Carrió,et al.  Indium-111-monoclonal antimyosin antibody studies after the first year of heart transplantation. Identification of risk groups for developing rejection during long-term follow-up and clinical implications. , 1990, Circulation.

[29]  J. Laragh,et al.  Relation of obesity, high sodium intake, and eccentric left ventricular hypertrophy to left ventricular exercise dysfunction in essential hypertension. , 1990, The American journal of medicine.

[30]  Y. Yazaki,et al.  Stretching cardiac myocytes stimulates protooncogene expression. , 1990, The Journal of biological chemistry.

[31]  K. Baker,et al.  [Sar1]angiotensin II receptor-mediated stimulation of protein synthesis in chick heart cells. , 1990, The American journal of physiology.

[32]  A. Katz.  Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. , 1990, The New England journal of medicine.

[33]  I. Carrió,et al.  High prevalence of myocardial monoclonal antimyosin antibody uptake in patients with chronic idiopathic dilated cardiomyopathy. , 1989, Journal of the American College of Cardiology.

[34]  I. Carrió,et al.  Indium-111 antimyosin scintigraphy to assess myocardial damage in patients with suspected myocarditis and cardiac rejection. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[35]  H. Gold,et al.  Acute myocardial infarct imaging with indium-111-labeled monoclonal antimyosin Fab. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[36]  N. Reichek,et al.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. , 1986, The American journal of cardiology.

[37]  R. Reba,et al.  Exercise radionuclide ventriculographic responses in hypertensive patients with chest pain. , 1984, The New England journal of medicine.

[38]  R. Prineas,et al.  Hypertension detection and follow-up program. Baseline electrocardiographic characteristics of the hypertensive participants. , 1983, Hypertension.

[39]  J. Fallon,et al.  Myocardial injury: quantitation by cell sorting initiated with antimyosin fluorescent spheres. , 1982, Science.

[40]  J. Laragh,et al.  Left Ventricular Hypertrophy and Function in High, Normal, and Low‐Renin Forms of Essential Hypertension , 1982, Hypertension.

[41]  M. Marcus,et al.  Effects of short- and long-term left ventricular hypertrophy on coronary circulation. , 1981, The American journal of physiology.

[42]  E. Haber,et al.  Myocardial infarct imaging of antibodies to canine cardiac myosin with indium-111-diethylenetriamine pentaacetic acid. , 1980, Science.

[43]  A. DeMaria,et al.  Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements , 1978, Circulation.

[44]  W Grossman,et al.  Wall stress and patterns of hypertrophy in the human left ventricle. , 1975, The Journal of clinical investigation.

[45]  W. Roberts,et al.  Ultrastructural features of degenerated cardiac muscle cells in patients with cardiac hypertrophy. , 1975, The American journal of pathology.

[46]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.

[47]  W. Kannel,et al.  The natural history of congestive heart failure: the Framingham study. , 1971, The New England journal of medicine.

[48]  D. Littmann.  The natural history of congestive heart failure. , 1971, The New England journal of medicine.

[49]  W. Kannel,et al.  Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study. , 1969, Annals of internal medicine.

[50]  F. Carreras,et al.  Spectrum of alcohol-induced myocardial damage detected by indium-111-labeled monoclonal antimyosin antibodies. , 1997, Journal of the American College of Cardiology.

[51]  H. Strauss,et al.  Monoclonal Antibodies in Cardiovascular Diseases , 1994 .

[52]  M. Sutton,et al.  Textbook of adult and pediatric echocardiography and doppler , 1989 .

[53]  K. Swedberg,et al.  Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.

[54]  F. Messerli.  The Heart and hypertension , 1987 .

[55]  Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1987, The New England journal of medicine.

[56]  N. Reichek.  Echocardiographic assessment of left ventricular hypertrophy. , 1982, European heart journal.

[57]  Meerson Fz.  On the mechanism of compensatory hyperfunction and insufficiency of the heart. , 1961 .

[58]  F. Meerson.  On the mechanism of compensatory hyperfunction and insufficiency of the heart. , 1961, Cor et vasa.